Xin Lang Cai Jing·2026-01-14 05:23Core Viewpoint - Junshi Biosciences' stock price has shown fluctuations, with a recent decline of 2.11%, while the company has experienced a year-to-date increase of 12.76% in stock value [1][2]. Group 1: Stock Performance - As of January 14, Junshi Biosciences' stock price is reported at 38.52 CNY per share, with a trading volume of 4.05 billion CNY and a market capitalization of 39.548 billion CNY [1]. - The stock has increased by 12.76% year-to-date, with a 1.90% rise over the last five trading days and a 5.30% increase over the last 20 days, while it has slightly decreased by 0.39% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Junshi Biosciences achieved a revenue of 1.806 billion CNY, representing a year-on-year growth of 42.06%. However, the net profit attributable to shareholders was -596 million CNY, reflecting a year-on-year increase of 35.72% in losses [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Junshi Biosciences is 35,900, which is an increase of 15.17% compared to the previous period. The average number of circulating shares per shareholder is 21,361, a decrease of 12.96% [2]. - Among the top ten circulating shareholders, E Fund's SSE STAR 50 ETF holds 19.3929 million shares, a decrease of 2.8203 million shares from the previous period, while Huaxia's SSE STAR 50 ETF holds 18.9720 million shares, down by 1.0745 million shares [3].